Clinical Trial Update: Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating a HIV vaccine therapy combined with incomplete Freund's adjuvant and GM-CSF; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• Incomplete Freund's adjuvant (Incomplete Freund's adjuvant)
• Vaccine therapy

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Nonneoplastic Condition | Phase 1 | Status: COMPLETED